130 related articles for article (PubMed ID: 8886012)
1. Repeated peripheral administration of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin alters the binding activities of 5-HT1A and 5-HT2 receptors in rat brain.
Muguruma K; Imamura K; Watanabe Y
Biochem Biophys Res Commun; 1996 Oct; 227(3):794-9. PubMed ID: 8886012
[TBL] [Abstract][Full Text] [Related]
2. 5-HT transporter sites and 5-HT1A and 5-HT3 receptors in Fawn-Hooded rats: a quantitative autoradiography study.
Chen F; Lawrence AJ
Alcohol Clin Exp Res; 2000 Jul; 24(7):1093-102. PubMed ID: 10924015
[TBL] [Abstract][Full Text] [Related]
3. Changes in the rat brain 5-HT1A and 5-HT2 receptors after chronic administration of levoprotiline, (+)-oxaprotiline and other antidepressant drugs.
Klimek V; Zak-Knapik J; Cannizzaro C
Pol J Pharmacol Pharm; 1992; 44(6):549-60. PubMed ID: 1305956
[TBL] [Abstract][Full Text] [Related]
4. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin.
Francis PT; Pangalos MN; Pearson RC; Middlemiss DN; Stratmann GC; Bowen DM
J Pharmacol Exp Ther; 1992 Jun; 261(3):1273-81. PubMed ID: 1534843
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment.
Welner SA; De Montigny C; Desroches J; Desjardins P; Suranyi-Cadotte BE
Synapse; 1989; 4(4):347-52. PubMed ID: 2532423
[TBL] [Abstract][Full Text] [Related]
7. [The characterization of 5-HT1A receptor in the central nervous system of the spontaneously hypertensive rats].
Liu BJ; Qiu XC
Sheng Li Xue Bao; 1994 Jun; 46(3):293-8. PubMed ID: 7973818
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
9. [Effects of different thyroid states on 5-HT1A receptor in adult rat brain].
Hong TP; Huang TY; Qiu XC
Sheng Li Xue Bao; 1992 Feb; 44(1):75-80. PubMed ID: 1598597
[TBL] [Abstract][Full Text] [Related]
10. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
Klimek V; Zak-Knapik J; Mackowiak M
J Psychiatry Neurosci; 1994 Jan; 19(1):63-7. PubMed ID: 8148368
[TBL] [Abstract][Full Text] [Related]
11. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.
Le Saux M; Di Paolo T
J Psychiatry Neurosci; 2005 Mar; 30(2):110-7. PubMed ID: 15798786
[TBL] [Abstract][Full Text] [Related]
12. [(3)H]-8-OH-DPAT binding in the rat brain raphe area: involvement of 5-HT(1A) and non-5-HT(1A) receptors.
Assié MB; Koek W
Br J Pharmacol; 2000 Jul; 130(6):1348-52. PubMed ID: 10903975
[TBL] [Abstract][Full Text] [Related]
13. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain.
Casanovas JM; Lésourd M; Artigas F
Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971
[TBL] [Abstract][Full Text] [Related]
14. Repeated cocaine administration does not affect 5-HT receptor subtypes (5-HT1A, 5-HT2) in several rat brain regions.
Javaid JI; Sahni SK; Pandey SC; Davis JM
Eur J Pharmacol; 1993 Jul; 238(2-3):425-9. PubMed ID: 8405113
[TBL] [Abstract][Full Text] [Related]
15. Potency of 5-hydroxytryptamine1a agonists to inhibit adenylyl cyclase activity is a function of affinity for the "low-affinity" state of [3H]8-hydroxy-N,N-dipropylaminotetralin ([3H]8-OH-DPAT) binding.
Chamberlain J; Offord SJ; Wolfe BB; Tyau LS; Wang HL; Frazer A
J Pharmacol Exp Ther; 1993 Aug; 266(2):618-25. PubMed ID: 8355195
[TBL] [Abstract][Full Text] [Related]
16. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
17. Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups.
Monte AP; Marona-Lewicka D; Parker MA; Wainscott DB; Nelson DL; Nichols DE
J Med Chem; 1996 Jul; 39(15):2953-61. PubMed ID: 8709129
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by repeated lithium treatment in rats.
Fujii T; Nakai K; Nakajima Y; Kawashima K
Can J Physiol Pharmacol; 2000 May; 78(5):392-9. PubMed ID: 10841434
[TBL] [Abstract][Full Text] [Related]
19. Prolonged corticosterone treatment alters the responsiveness of 5-HT1A receptors to 8-OH-DPAT in rat CA1 hippocampal neurons.
Czyrak A; Maćkowiak M; Chocyk A; Fijał K; Tokarski K; Bijak M; Wedzony K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):357-67. PubMed ID: 12237750
[TBL] [Abstract][Full Text] [Related]
20. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
Burnet PW; Eastwood SL; Harrison PJ
Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
